Abstract
Bcr-Abl tyrosine kinase activity is essential for the pathogenesis of chronic myeloid leukemia (CML). A number of Bcr-Abl substrates have been identified, but it is not clear which of these substrates are required for Bcr-Abl to transform cells. The multifunctional protein c-Cbl is one of the most prominently tyrosine-phosphorylated proteins in Bcr-Abl-expressing cells. Using cell lines and mice with homozygous disruption of the c-CBL locus, we investigated the role of this protein for Bcr-Abl-driven transformation. We find that although c-Cbl−/− fibroblast cell lines show a deficit in Bcr-Abl transformation compared to wild-type (Wt) cells, this deficit was less pronounced in c-Cbl−/− B cells derived from murine bone marrow. Most importantly, in a transplantation model of CML, Bcr-Abl was capable of inducing fatal leukemia in mice in the absence of c-Cbl protein. Our results indicate that c-Cbl is dispensable for Bcr-Abl-induced leukemogenesis in mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andoniou CE, Thien CB and Langdon WY . (1994). EMBO J., 13, 4515–4523.
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T and Stone M, et al. (1983). Nature, 306, 277–280.
Beitz LO, Fruman DA, Kwosaki T, Cantley LC and Scharenberg AM . (1999). J. Biol. Chem., 274, 32662–32666.
Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C and Druker BJ . (1997). J. Biol. Chem., 272, 16170–16175.
Chan LC, Kahi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves ML and Wiedemann L . (1987). Nature, 325, 635–637.
Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD and Witte ON . (1988). Science, 239, 775–777.
Cortez D, Kadlec L and Pendergast AM . (1995). Mol. Cell Biol., 15, 5531–5541.
Daley G and Baltimore D . (1988). Proc. Natl. Acad. Sci. USA, 85, 9312–9316.
Daley GQ, Van Etten RA and Baltimore D . (1990). Science, 247, 824–830.
de Jong R, ten Hoeve J, Heisterkamp N and Groffen J . (1995). J. Biol. Chem., 270, 21468–21471.
deKlein A, Hagemeijer A, Bartram CR, Houwen R, Hoefstool L, Carbonell F, Barnett M, Greaves ML, Kliehauer E, Heisterkamp N, Groffen J and Grosveld G . (1986). Blood, 68, 1369–1375.
Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L and Pandolfi PP . (2001). J. Exp. Med., 194, 275–284.
Donovan JA, Wange RL, Langdon WY and Samelson LE . (1994). J. Biol. Chem., 269, 22921–22924.
Elefanty AG, Hariharan IK and Cory S . (1990). EMBO J., 9, 1069–1078.
Fang D, Wang HY, Fang N, Altman Y, Elly C and Liu YC . (2001). J. Biol. Chem., 276, 4872–4878.
Feinstein E, Marcelle C, Rosner E, Canaani E, Gale RP, Dreazen O, Smith SD and Croce CM . (1987). Nature, 330, 386–388.
Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE and Band H . (1995). J. Biol. Chem., 270, 19141–19150.
Gale RP and Goldman JM . (1988). Leukemia, 2, 321–324.
Galisteo ML, Dikic I, Batzer AG, Langdon WY and Schlessinger J . (1995). J. Biol. Chem., 270, 20402–20405.
Gaston I, Stenberg PE, Bhat A and Druker BJ . (2000). Exp. Hematol., 28, 77–86.
Goga A, McLaughlin J, Afar DE, Saffran DC and Witte ON . (1995). Cell, 82, 981–988.
Goldman A . (1998). Cells: A Laboratory Manual Spector DL, Goldman RD, Leinwand LA (eds). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp. 4.1–4.7.
Gotoh A and Broxmeyer HE . (1997). Curr. Opin. Hematol., 4, 3–11.
Hamilton E, Miller KM, Helm KM, Langdon WY and Anderson SM . (2001). J. Biol. Chem., 276, 9028–9037.
Hariharan JK, Adams JM and Cory S . (1988). Oncogene Res., 3, 387–399.
Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR and Grosveld G . (1983). Nature, 306, 239–242.
Hemmeryckx B, Reichert A, Watanabe M, Kaartinen V, de Jong R, Pattengale PK, Groffen J and Heisterkamp N . (2002). Oncogene, 21, 3225–3231.
Hermans A, Heisterkamp N, von Baal S, Meijer D, van der Plass D, Wiedemann LM, Groffen J, Bootsma D and Grosveld G . (1987). Cell, 51, 33–40.
Hess P, Pihan G, Sawyers CL, Flavell RA and Davis RJ . (2002). Nat. Genet., 32, 201–205.
Ilaria Jr RL and Van Etten . (1995). Blood, 86, 3897–3904.
Ilaria Jr RL and Van Etten RA . (1996). J. Biol. Chem., 271, 31704–31710.
Jain SK, Langdon WY and Varticovski L . (1997). Oncogene, 14, 2217–2228.
Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999). Science, 286, 309–312.
Kaplan MH, Schindler U, Smiley ST and Grusby MJ . (1996). Immunity, 4, 313–319.
Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC and Lipkowitz S . (1995). Oncogene, 10, 2367–2377.
Kelliher MA, McLaughlin J, Witte ON and Rosenberg N . (1990). Proc. Natl. Acad. Sci. USA, 87, 6649–6653.
Kelliher MA, Weckstein DJ, Knott AG, Wortis HH and Rosenberg N . (1993). Oncogene, 8, 1249–1256.
Konopka JB, Watanabe SM and Witte ON . (1984). Cell, 37, 1035–1042.
Kurzrock R, Gutterman JU and Talpaz M . (1988). N. Engl. J. Med., 319, 990–998.
Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG and Van Etten RA . (2001). Blood, 97, 1442–1450.
Li S, Illaria RL, Million RP, Daley GQ and Van Etten RA . (1999). J. Exp. Med., 189, 1399–1412.
Lugo TG, Pendergast A-M, Muller AJ and Witte ON . (1990). Science, 247, 1079–−1082.
Lugo TG and Witte ON . (1989). Mol. Cell Biol., 9, 1263–1270.
McLaughlin J, Chianese E and Witte ON . (1987). Proc. Natl. Acad. Sci. USA, 84, 6558–6562.
McLaughlin J, Chianese E and Witte ON . (1989). Mol. Cell Biol., 9, 1866–1874.
Melo JV . (1996). Blood, 88, 2375–2384.
Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR and Witte ON . (1991). Mol. Cell Biol., 11, 1785.
Mushinski JF, Goodnight J, Rudikoff E, Morse III HC and Langdon WY . (1994). Oncogene, 9, 2489–2497.
Naramura M, Kole HK, Hu RJ and Gu H . (1998). Proc. Natl. Acad. Sci. USA, 95, 15547–15552.
Odai H, Sasaki K, Iwamatsu A, Hanazono Y, Tanaka T, Mitani K, Yazaki Y and Hirai H . (1995). J. Biol. Chem., 270, 10800–10805.
Okuda K, Golub TG, Gilliland DG and Griffin JD . (1996). Oncogene, 13, 1147–1152.
Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML and Baltimore D . (1998). Blood, 92, 3780–3792.
Pear WS, Nolan GP, Scott ML and Baltimore D . (1993). Proc. Natl. Acad. Sci. USA, 90, 8392–8396.
Pendergast AM, Quilliam CA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Des CJ and Schlessinger J . (1993). Cell, 75, 175–185.
Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D and Heinrich MC . (2001). Cancer, 93, 269–275.
Raitano AB, Whang YE and Sawyers CL . (1997). Biochim. Biophys. Acta, 1333, 201–216.
Rao N, Dodge I and Band H . (2002). J. Leukoc. Biol., 71, 753–763.
Rowley JD . (1973). Nature, 243, 290.
Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H, Salgia R, Lipkowitz S and Griffin JD . (2002). Oncogene, 2, 1423–1433.
Sattler M and Salgia R . (1997). Cytokine Growth Factor Rev., 8, 63–79.
Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV and Griffin JD . (1996). Oncogene, 12, 839–846.
Sawyers CL . (1997). Baillieres Clin. Haematol., 10, 223–231.
Sefton BM, Hunter T and Raschke WC . (1981). Proc. Natl. Acad. Sci., 78, 1552–1556.
Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF and Ihle JN . (2000). Blood, 96, 2277–2283.
Tanaka S, Neff L, Baron R and Levy JB . (1995). J. Biol. Chem., 270, 14347–14351.
Young JC and Witte ON . (1988). Mol. Cell Biol., 8, 4079–4087.
Zhang X and Ren R . (1998). Blood, 92, 3829–3840.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dinulescu, D., Wood, L., Shen, L. et al. c-CBL is not required for leukemia induction by Bcr-Abl in mice. Oncogene 22, 8852–8860 (2003). https://doi.org/10.1038/sj.onc.1206892
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206892
Keywords
This article is cited by
-
Inverse regulation of bridging integrator 1 and BCR-ABL1 in chronic myeloid leukemia
Tumor Biology (2016)
-
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
Leukemia (2013)
-
CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing
Leukemia (2013)
-
Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia
Nature Reviews Cancer (2005)